The 2024 European Society of Cardiology (ESC ... with suspected ANOCA/INOCA who do not respond to guideline-derived medical therapy should undergo invasive coronary functional testing to determine ...

Twenty-one scientists from the rhythmological societies of Europe (European Heart Rhythm Association), North America (Heart Rhythm Society), South ... to innovative imaging and diagnostic ...

A University of Dundee study has discovered the potential for Artificial Intelligence to transform care for heart failure ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced four ab ...

today announced the publication of an abstract regarding PRT3789 at the European Society of Medical Oncology (ESMO) Congress 2024 taking place in Barcelona, Spain September 13-17, 2024.

A copy of the presentation materials can be accessed on the “Publication” section of the Company’s website at www.bioatla.com once the presentation has concluded. About BioAtla®, Inc.

6, 2024 /PRNewswire/ -- SIFI, a leading international ophthalmic company, is pleased to announce that it will present two product innovations and new scientific data during the upcoming Congress of ...

Avacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted cancer treatments and powerful diagnostics, today announces that the company will present updated data from the ...

Using a scoring system established a decade ago by the European Society of Medical Oncology (ESMO) to identify which approvals provide the highest clinical benefit, the researchers sorted the ...

During a keynote presentation at the European Society for Medical Oncology (ESMO) Congress 2024 in Barcelona, Spain, Ogino explained that data from 2007 to 2017 show that 25% of patients with ...